Manage Your Liver
Q:

Prevent liver cell damage: A new era of liver disease treatment

Prevent liver cell damage: A new era of liver disease treatment
A:

There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.

 

The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Therefore, pharmaceutical companies have recently shifted their focus onto the development of cure for fatty liver and NASH.

 

As the cause of NASH is still unknown, to date, there are no available treatment options. Unlike hepatitis C, where the liver damage is caused by hepatitis viruses; the only thing we know about NASH is that the accumulated fat is related to liver injury, but the mechanism is unknown. . In this case, anti-viral medication will not be effective for NASH patients.

 

New drug in development focuses on preventing liver cell damage

New drugs for NASH are in development,  they are designed to block the progression of liver cell damage, prevent chronic liver inflammation and cirrhosis, and ultimately help to improve liver function for NASH patients.

 

Pharmaceutical companies are hoping that this new drug can minimize liver injury and help NASH patients to reduce risk of developing chronic liver diseases. The drug is currently under clinical trial; enrolment of a final-stage trial of 2,000 people is expected to be completed next year, with interim results due in 2019. Early results show that the new drug can lower patients’ ALT level, which is a good indication that liver injury is reduced. [2] 

 

New drugs may improve but not normalize liver function

The use of chemicals and drugs in treating liver diseases has its downsides. Patients are required to use the inhibitor in the long term in order to prevent liver injury this means that they will be consuming chemicals and toxins on a daily basis. Regardless of the intensity of side effects, long term use of any medication will no doubt negatively affect our health.

 

This might be the reason why the new drugs in development are unable to normalize ALT and liver function, even though liver damage may be reduced. These drugs themselves contain toxic substances which are harmful to our bodies in some way.

 

If you want to know more about the upcoming new drugs and how YHK can help to stop NASH, please contact our support team!

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Being the most serious form of liver disease, liver cancer is on the rise globally. While we have always known that liver cancer doesn’t develop overnight, there have not been many studies that investigate the potential risks for liver cancer for patients with liver diseases. According to a recent research conducted by the AGA Institute, it was found out that non-alcoholic fatty liver disease (NAFLD) patients have a higher risk of developing a dangerous liver cancer called hepat
A:
Cirrhosis has always been a tricky liver condition to tackle, given its complications and symptoms that are difficult to manage. A recent study published in the American Journal of Physiology-Gastrointestinal and Liver Physiology mentions that lowering the inflammation level of cirrhosis patients’ oral cavity helps improve the overall inflammation level in the body, which could help minimize some of the symptoms cirrhosis patients experience. This study highlights the i
Hit Questions
A:
The liver carries out essential functions, including detoxifying harmful substances in your body, cleaning your blood and making new blood and other vital nutrients. Cirrhosis is scarring of the liver caused by long-term liver damage. The loss of liver cells turns into scar tissue which prevents the liver working normally, reducing or in some cases, completely losing liver function. Cirrhosis is a long-term chronic liver damage; it is often caused by chronic live
A:
ALT (Alanine Aminotransferase / SGPT) is a type of enzyme found in liver cells. When the liver cells are functioning normally, the ALT enzymes should be contained within the liver cells.    You can imagine each liver cells as a balloon, and the ALT enzymes are the air inside the balloon. When the balloon is damaged, the air will be released. And when the liver cells is damaged, ALT enzymes are released into the bloodstream, therefore we are able to find out the l
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us
Subscribe To Our Mailing List And
Never Miss Another Great Promotion!
Join our mailing list to receive latest new about our company, plus health articles. You will also be able to receive early bird discount from us!
Maybe Later, Thank you.
Subscribe success! You will receive latest new soon.